Brief: Salarius Pharmaceuticals Reports Q4 And Full Year 2023 Results

Decoy Therapeutics

22/03/2024 20:09

March 22 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * AS OF DECEMBER 31, 2023, SALARIUS HAD CASH, CASH
EQUIVALENTS AND
RESTRICTED CASH OF $5.9 MILLION
    * CURRENT CASH AND CASH EQUIVALENTS ARE EXPECTED TO FUND
COMPANY'S
PLANNED OPERATIONS INTO FIRST HALF OF 2025
    * NET LOSS FOR Q4 OF 2023 WAS $0.9 MILLION, OR $0.22 PER
SHARE
    * Q3 EARNINGS PER SHARE VIEW $-1.20 -- LSEG IBES DATA

Source text for Eikon:  ID:nGNX6Cs3g8 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))